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Introduction
Prevention of venous thromboembolism (VTE) after total knee
arthroplasty (TKA) is a very important issue. Risk factors of VTE
in TKA have not been identified, with the exception of prior VTE
and aging,1 but TKA per se is reportedly a significant risk factor
for VTE.2 Clinically, use of a pneumatic tourniquet is considered
one of the most important risk factors for the occurrence of symp-
tomatic VTE. Parmet et al. demonstrated that use of a tourniquet
during TKA is associated with a greater risk of ultrasound-detected
VTE.3 Furthermore, Kato et al. recommended that TKA should be
performed without a tourniquet to reduce the risk of large venous
emboli.4 We recently reported that use of a tourniquet in TKA rep-
resents a risk factor for pulmonary thromboembolism (PTE).5,6 In
those study, PTE was detected in 2 (40.0%) of 5 patients who un-
derwent bilateral TKAs with tourniquet, 1 (7.1%) of 14 patients who
underwent unilateral TKA with tourniquet, 3 (7.1%) of 42 patients
who underwent bilateral TKAs without tourniquet, and no patients
who underwent unilateral TKA without tourniquet. Conversely, a
tourniquet also minimizes intraoperative blood loss. Several stud-
ies have discussed the management of blood loss in unilateral TKA
without using a tourniquet,7,8 but none have examined this issue
with bilateral TKAs. Sehat et al. reported that in TKA, total blood
loss comprises "visible" blood loss from the surgical field and
wound drainage, and "invisible" loss into tissues.9
The aim of the present study was to provide an accurate estimate
of "invisible" intraoperative blood loss in TKA with and without
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Total knee arthroplasty (TKA) without a tourniquet can reduce the risk of large venous emboli, but is associated with increased blood loss.
To provide an accurate estimate of this blood loss, we divided 136 patients who underwent primary TKA into four groups based on the type of
operation: 1) bilateral TKA with tourniquet; 2) bilateral TKA without tourniquet; 3) unilateral TKA with tourniquet; and 4) unilateral TKA without
tourniquet. Blood loss was estimated by calculating the fall in hemoglobin and total blood volume corrected for Japanese. A small difference
in intraoperative blood loss was seen between unilateral TKA without tourniquet (308 ml) and bilateral TKA without tourniquet (411 ml). Total
blood loss was 879 ml in unilateral TKA with tourniquet, 1165 ml in unilateral TKA without tourniquet, 1458 ml in bilateral TKA with tourniquet
and 1823 ml in bilateral TKA without tourniquet. Uni- and bilateral TKAs without a tourniquet were thus associated with an increased blood loss.
Performing TKA without a tourniquet should thus be reconsidered to avoid venous thromboembolism.
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Cross Atomic Bomb Memorial Hospital (Nagasaki, Japan). These
patients were eligible for enrolment in the study and provided signed
informed consent. Of these, 73 patients who received intraoperative
blood transfusion at Days 0, 1 and 2 were excluded from the study.
Blood transfusion was provided for patients with clinical symp-
toms related to acute blood loss such as shock, hypotension,
tachycardia, and those with preoperative hemoglobin level <10.0
mg/dl, postoperative hemoglobin level <7.0 mg/dl and elderly pa-
tients >85 years old. Furthermore, another patient who underwent
bilateral TKAs with a tourniquet was also excluded due to the de-
velopment of postoperative infection. As a result, 136 patients
were enrolled for further analysis. Among these, underlying pa-
thology was rheumatoid arthritis in 41 patients (7 men, 34 women)
and osteoarthritis in 95 patients (16 men, 79 women). Mean age of
all patients was 71 years (range, 29-87 years).
According to the operative procedure, each patient was assigned
to one of the following groups: 1) bilateral TKA with tourniquet
(n=11); 2) bilateral TKA without tourniquet (n=42); 3) unilateral
TKA with tourniquet (n=41); and 4) unilateral TKA without tour-
niquet (n=42). Patients receiving bilateral TKA with tourniquet un-
derwent surgery between May 2000 and February 2001, while
those receiving bilateral TKA without tourniquet underwent sur-
gery between March 2001 and April 2003. Similarly, patients re-
ceiving unilateral TKA with tourniquet and unilateral TKA without
tourniquet underwent surgery from May 2000 to February 2001
and from March 2001 to April 2003, respectively. Clinical profiles
of each group are summarized in Table 1.
All procedures were performed by two surgeons (M.N. and
M.K.) using similar surgical techniques. A skin incision was made
at the center of the knee joint. A medial parapatellar approach for
genu varum was performed through the retinaculum, capsule and
synovium. For cases with genu valgum, the lateral approach was
applied. An intramedullary guide was used for the femur and an
extramedullary guide was used for the tibia. When lateral release
was necessary, blood supply from the superior or inferior geniculate
artery was preserved. Partial synovectomy was performed and in-
cluded the suprapatellar bursa only to avoid impingement. A 3-mm
suction drain was placed deep into the retinaculum of the knee
joint. The drain was removed 24-48 h after operation, when the
tube became clogged with coagulate or when volume of suction
fluid (blood) was <50 ml in 6 h. Full weight-bearing was started
immediately after the procedure. None of the patients required
drain replacement. A NexGen Total Knee System (Zimmer, Inc.,
Warsaw, Indiana, USA) was used in 122 cases (77 unilateral, 45
bilateral), and the posterior cruciate ligament (PCL) was retained
in these cases. The LCS Total Knee System (Depuy International,
Leeds, UK) with PCL sacrifice was used in 14 cases (6 unilateral,
8 bilateral).
Unilateral TKA was performed under spinal anesthesia, whereas
bilateral TKA was conducted under general anesthesia (using
hypotensive anesthesia).
None of the patients had experienced previous VTE or had ad-
vanced malignancy. No patients received perioperative anticoagulant
therapies such as oral administration of warfarin or aspirin, venous
injection of heparin, or subcutaneous injection of low-molecular-
weight heparin from 7 days preoperatively to 14 days postoperatively,
excluding those patients who developed PTE postoperatively.
Furthermore, no foot pump was required by any patients after sur-
gery. For the purposes of pain control, diclofenac (a non-steroidal
anti-inflammatory drug) was used orally or in suppository form in
all patients during the early postoperative period.
Measurement of hemoglobin
Hemoglobin was measured pre- and postoperatively (Days 1, 3
and 7) at 09:00. Minimum postoperative hemoglobin value was de-
fined as the lowest value during 1 week without blood transfusion.
Maximum decrease in hemoglobin was defined as (preoperative
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Unilateral TKA Bilateral TKA Total
Intraoperative tourniquet with without with without (n=136)
(n=41) (n=42) (n=11) (n=42)
RA/OA 20/21 14/28 1/10 6/36 41/95
Male/Female 3/38 7 : 35 2/9 11/31 23/113
Age (years)* (63, 66, 73) (64, 71, 77) (70, 73, 76) (68, 72, 76) (64, 71, 75)
29-84 42-87 65-80 53-84 29-87
Weight (kg)* (47.5, 55.0, 61.5) (46.5, 53.8, 61.5) (46.5, 50.0, 64.0) (55.8, 60.9, 69.6) (49.5, 57.0, 64.4)
41.0-71.0 36.0-81.0 42.0-66.0 41.0-90.0 36.0-90.0
Height (m)* (1.44, 1.50, 1.55) (1.44, 1.48, 1.55) (1.43, 1.49, 1.50) (1.48, 1.52, 1.58) (1.45, 1.50, 1.56)
133-161 1.37-1.67 1.40-1.64 1.39-1.73 1.33-1.73
BMI (kg/m2)* (21.4, 24.9, 27.9) (21.7, 24.3, 26.9) (20.7, 24.5, 28.1) (23.6, 26.6, 30.6) (22.3, 25.4, 28.4)
17.3-32.7 15.7-32.0 18.7-30.2 19.7-36.8 15.7-36.8
TBV (L) (3.15, 3.68, 4.08) (3.11, 3.51, 4.10) (3.11, 3.28, 4.18) (3.67, 4.10, 4.69) (3.28, 3.76, 4.29)
2.68-4.76 2.24-5.17 3.00-4.46 2.60-5.73 2.24-5.73
Table 1. Clinical profiling of patients who underwent total knee arthropathy (TKA).
*Data are expressed as (1st quartile, median, 3 rd quartile)
minimum-maximum
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hemoglobin level - minimum hemoglobin level).
Measurement of intra- and postoperative blood loss
"Intraoperative blood loss" was defined as the sum of the weight
change in surgical gauzes and the fluid level of suction reservoirs,
and "measured postoperative blood loss" was defined as the total
volume collected in the closed-drainage system. Finally, "meas-
ured total blood loss" was determined as the sum of "intraoperative
blood loss" and "measured postoperative blood loss".
Calculation formulae
Total blood loss was calculated using the following formula:
total blood volume (TBV) × (1 - postoperative minimum hemo-
globin / preoperative hemoglobin).10 TBV was defined as (0.168
H3 + 0.050 W + 0.444) L for Japanese men, and (0.250 H3 + 0.063
W - 0.662) L for Japanese women, where H was height in meters
and W was weight in kilograms.11 Calculated blood loss was de-
fined as TBV × (1 - postoperative minimum hemoglobin / postop-
erative hemoglobin).12 Postoperative blood loss was also deter-
mined as (total blood loss - intraoperative blood loss).
Statistical analysis
Data are expressed as median (range). Differences in blood loss
between the four patient groups were examined for statistical sig-
nificance using the Mann-Whitney rank-sum test. Values of P
<0.05 denoted the presence of a significant difference. SPSS for
Windows version 11.0 software (SPSS, Chicago, IL) was used for
all analyses.
Results
Profiling and perioperative blood loss are shown in Table 2. No
differences were seen between pre- and postoperative minimum
hemoglobin levels between uni- and bilateral TKA groups. Operation
times were significantly longer for uni- and bilateral TKA without
tourniquet groups compared to the respective tourniquet groups
(p<0.001, p=0.005, respectively).
Intraoperative blood loss was significantly greater in uni- and bi-
lateral TKA without tourniquet groups than in the respective tour-
niquet groups (p<0.001, p<0.001, respectively). However, no sig-
nificant difference in intraoperative blood loss was seen between
unilateral TKA without tourniquet (308 ml) and bilateral TKA
without tourniquet (411 ml).
Measured and calculated total blood losses in uni- and bilateral
TKA without tourniquet were significantly greater than those in
the respective tourniquet groups (p<0.001, 0.002, 0.001 and 0.004,
respectively). Calculated postoperative blood loss did not differ
significantly between unilateral TKA without tourniquet and uni-
lateral TKA with tourniquet (p=0.45) or between bilateral TKA
without tourniquet and bilateral TKA with tourniquet (p=0.98).
Calculated total blood losses in unilateral TKA with tourniquet and
unilateral TKA without tourniquet were 879 ml and 1165 ml, re-
spectively. Calculated total blood losses in bilateral TKA with
tourniquet and bilateral TKA without tourniquet were 1458 ml and
1823 ml, respectively. Small differences in calculated total blood
loss were thus seen between unilateral TKA with tourniquet and
unilateral TKA without tourniquet (286 ml) and between bilateral
TKA with tourniquet and bilateral TKA without tourniquet (365
ml).
"Invisible" losses represent 75.0% and 42.3% of total losses in
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Unilateral TKA Bilateral TKA
Intraoperative tourniquet with (n=41) without (n=42) p with (n=11) without (n=42) p
Preoperative Hb (mg/dl) (11.2, 12.1, 13.3) (11.7, 13.1, 13.5) 0.059 (11.3, 12.5, 12.9) (12.7, 13.3, 14.1) 0.037
9.1-14.6 9.6-15.2 10.4-15.3 10.8-16.2
Postoperative minimum (7.8, 9.1, 10.0) (7.7, 8.4, 9.1) 0.082 (6.3, 7.1, 8.4) (6.9, 7.2, 8.0) 0.363
Hb (mg/dl) 6.4-11.2 5.6-13.0 6.0-10.0 5.7-9.5
Operation time (minutes) (72, 79, 88) (84, 97, 110) <0.001 (152, 163, 181) (176, 188, 216) 0.005
55-120 64-188 126-259 146-289
Intraoperative blood loss (ml)*† (0, 0, 4.5) (179, 308, 440) <0.001 (0, 0, 71) (266, 409, 528) <0.001
0-46 60-793 0-169 105-1231
Measured total blood loss (ml)*† (114, 220, 308) (442, 672, 865) <0.001 (209, 329, 602) (731, 987, 1157) 0.001
8-739 130-1223 130-1159 438-2084
Calculated total blood loss (ml)* (724, 879, 1229) (1001, 1165, 1563) 0.002 (1220, 1458, 1639) (1517, 1823, 2192) 0.004
369-2019 421-2221 980-1928 1093-2548
Postoperative total blood loss (ml)* (724, 875, 1229) 838 (133-1655) 0.452 (1147, 1458, 1554) (1077, 1420, 1817) 0.983
345-2014 133-1655 963-1928 614-2112
Blood transfusion (unit)*‡ (0, 0, 0) (0, 0, 0) 0.951 2.0 2.0 0.762
0-4.0 0-4.0 0-4.0 0-8.0
Table 2. Bleeding events in patients who underwent TKA with and without tourniquet.
* Data are expressed as (1st quartile , median, 3 rd quartile)
minimum-maximum
†Volume of blood loss dur ing operation was recorded by suction system and surgical gauze.
‡Japanese unit of packed red blood cells is not a universal standard
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unilateral TKA with tourniquet and unilateral TKA without tourni-
quet, respectively, and 77.4% and 44.7% of total losses in bilateral
TKA with tourniquet and bilateral TKA without tourniquet, re-
spectively. Finally, no significant difference in volume of blood
transfusion was seen between unilateral TKA with tourniquet and
unilateral TKA without tourniquet (p=0.951), or between bilateral
TKA with tourniquet and bilateral TKA without tourniquet
(p=0.762).
Discussion
Most orthopedic surgeons use a pneumatic tourniquet in TKA to
reduce intraoperative blood loss and maintain a bloodless surgical
field. Harvey et al. reported that use of the tourniquet may theoreti-
cally increase the risk of deep vein thrombosis (DVT) through ve-
nous stasis, direct trauma to the vessel wall, and increased platelet
adhesion in valve pockets secondary to distal limb ischemia.7
Furthermore, Parmet et al. reported that the incidence of PTE after
TKA with tourniquet is higher than that without tourniquet.3 We
recently reported the plasma levels of D-dimer, a sensitive serum
marker of VTE (defined as the combination of DVT and PTE),
were significantly higher in patients with tourniquet than in those
without tourniquet, in both unilateral and bilateral TKAs.5 Causes
of PTE after TKA include surgical factors such as tourniquet use
and intramedullary guide into the femur, and patient-related risk
factors such as existence of DVT and hypercoagulable status.13
When TKA is performed without a tourniquet, thrombosis and fat
embolism may not be suddenly released into the pulmonary arter-
ies.
The major problem associated with TKA without a tourniquet is
increased blood loss, but few studies have attempted to evaluate
this matter. To estimate blood loss, several calculation formulae
have been developed10,14,15 and used in various studies to estimate
total blood loss in unilateral TKA.8,9,12,16 These formulae calculate
the maximum decrease in hemoglobin or hematocrit based on pre-
and postoperative values and total blood volume normalized to the
weight and height of the patient. The present study estimated blood
loss by calculating decreases in hemoglobin and total blood vol-
ume corrected for Japanese individuals.11
Gross reported that linear formulae, which imply that the fraction
decrease in hemoglobin is equal to the fraction of total blood vol-
ume that has been lost, overestimate hemoglobin loss because each
milliliter of shed blood contains progressively less hemoglobin,
particularly in patients with an initial hematocrit >45%. Use of a
logarithmic approximation formula was thus recommended.10
Bourke and Smith reported that within physiological ranges, differ-
ences between linear and logarithmic formulae are clinically negli-
gible.14 The present study therefore applied a linear formula due to
the advantage of mathematical simplicity. Hemoglobin level was
used because of the utility as a criterion for blood transfusion.
Our results suggest that TKA without tourniquet influences op-
eration time, intraoperative blood loss and calculated total blood
loss. The operation without tourniquet was 16 min longer for uni-
lateral TKA and 25 min longer for bilateral TKA. Intraoperative
blood loss without tourniquet was 308 ml in unilateral TKA and
411 ml in bilateral TKA. Intraoperative blood loss in unilateral
TKA without tourniquet was reported as 295 ml by Tetro et al.8
The difference in calculated total blood loss between with and
without a tourniquet was <300 ml with unilateral TKA and <400
ml with bilateral TKA. Evaluation of intraoperative blood loss and
calculated total blood loss is quite important for the management
of blood transfusion in patients who undergo TKA without a tour-
niquet.
According to our results for calculated total blood loss in TKA
(Table 2), necessary transfusion volumes for safe surgical proce-
dures in uni- and bilateral TKA without tourniquet were estimated
as approximately 1200 ml and 1800 ml, respectively. Conversely,
required transfusion volumes for ordinary procedures in uni- and
bilateral TKA with tourniquet were estimated as approximately
800 ml and 1400 ml, respectively. Preparation of autologous red
blood cells or allogeneic blood would be needed for these proce-
dures in TKA.
The benefit of tourniquet use for the prevention of blood loss in
TKA remains controversial. Harvey et al. reported estimated blood
losses in unilateral TKA with and without tourniquet of 709 ml and
1493 ml, respectively, and incidence of DVT did not correlate with
tourniquet use.7 Conversely, Tetro et al. reported that calculated
total blood loss in unilateral TKA with and without tourniquet was
1792 ml and 1499 ml, respectively, and effectiveness of a pneumatic
tourniquet to control blood loss in TKA was questionable.8 In an-
other study, Abdel-Salam et al. reported no significant differences
between TKA with and without tourniquet with regard to operation
time and blood loss, but less postoperative pain was experienced
by patients in whom no tourniquet had been used.17 On the other
hand, Wakankar et al. concluded that use of a tourniquet is safe
and recommended continuation of the current practice.18
Sehat et al. reported calculated total blood loss in unilateral
TKA with tourniquet as 1474 ml.9 The loss was reported as 1518
ml by Lotke et al.12 and 1426 ml by Good et al.16 In the present
study, calculated total blood losses in unilateral TKA with and with-
out tourniquet were 879 ml and 1165 ml, respectively. Differences
in these volumes between studies might be due to factors such as
hypotensive anesthesia, operation time, re-infusion drain, ethnicity,
total blood volume and body size. To the best of our knowledge,
this is the first study to estimate blood loss in bilateral TKA with-
out a tourniquet.
In our study, "invisible" loss with and without tourniquet was
75.0% and 42.3% of total loss in unilateral TKA, and 77.4% and
44.7% in bilateral TKA, respectively. Sehat et al. indicated that
this potential problem must be recognized and addressed when
clinically indicated.9
The present pilot study showed several limitations. The sample
size was relatively small, and the study was neither prospective nor
randomized. Furthermore, we included patients with rheumatoid
arthritis as well those with osteoarthritis. To reduce the incidence
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of postoperative VTE in patients who undergo TKA, further stud-
ies are needed to re-evaluate tourniquet use in TKA in terms of
blood loss and prevention of VTE.
In conclusion, TKA without tourniquet increased blood loss by
less than 400 ml compared to TKA with tourniquet. Postoperative
blood loss was the same in both procedures, according to our cal-
culation. If use of a tourniquet during TKA represents a risk factor
for VTE following TKA, TKA without tourniquet is safer than
TKA with tourniquet in terms of life-threatening VTE. Further
countermeasures to minimize intraoperative blood loss during TKA
without tourniquet are needed.
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